Isosilybin A
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Isosilybin A
Description:
Isosilybin A is a PPARγ agonist that can be isolated from silymarin. Isosilybin A activates extrinsic and intrinsic pathways of apoptosis through targeting of the Akt-NF-kB-AR axis. Isosilybin A can relieve the inflammatory response in the rosacea model via inhibiting Erk and p38 signaling pathways and M1 macrophage polarization, with its targets related to RELA and VEGFA. Isosilybin A has anti-prostate cancer (PCA) activity[1][2][3].UNSPSC:
12352005Hazard Statement:
H302Target:
Androgen Receptor; Apoptosis; ERK; NF-κB; p38 MAPK; PPARType:
Natural ProductsRelated Pathways:
Apoptosis; Cell Cycle/DNA Damage; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB; Stem Cell/Wnt; Vitamin D Related/Nuclear ReceptorApplications:
Cancer-programmed cell deathField of Research:
Cancer; Inflammation/ImmunologyAssay Protocol:
https://www.medchemexpress.com/isosilybin-a.htmlConcentration:
10mMPurity:
99.63Solubility:
DMSO : 100 mg/mL (ultrasonic)Smiles:
O=C1[C@H](O)[C@@H](C2=CC=C(O[C@H](C3=CC=C(O)C(OC)=C3)[C@@H](CO)O4)C4=C2)OC5=CC(O)=CC(O)=C15Molecular Formula:
C25H22O10Molecular Weight:
482.44Precautions:
H302References & Citations:
[1]Wu CC, et al. Isosilybin A exhibits anti-inflammatory properties in rosacea by inhibiting MAPK pathway and M1 macrophage polarization. Int Immunopharmacol. 2024 Dec 25;143 (Pt 1) :113323. |[2]Pferschy-Wenzig EM, et al. Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gamma. J Nat Prod. 2014 Apr 25;77 (4) :842-7.|[3]Deep G, et al. Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling. Mol Carcinog. 2010 Oct;49 (10) :902-12.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedCAS Number:
[142796-21-2]
